Response Oncology, Inc. Share Price

Equities

ROIX

US7612323052

Healthcare Facilities & Services

Market Closed - OTC Markets 07:00:50 22/08/2023 pm IST 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Response Oncology, Inc. -.--% -.--%
Sales 2000 13Cr 1.09TCr Sales 2001 12Cr 986.45Cr Capitalization 7L 5.65Cr
Net income 2000 -1.4Cr -116.95Cr Net income 2001 -5.1Cr -426.04Cr EV / Sales 2000 0.24 x
Net Debt 2000 2.78Cr 231.92Cr Net Debt 2001 1.86Cr 155.59Cr EV / Sales 2001 0.16 x
P/E ratio 2000
-0.21 x
P/E ratio 2001
-0.01 x
Employees -
Yield 2000 *
-
Yield 2001
-
Free-Float 99.22%
More Fundamentals * Assessed data
Dynamic Chart
5 years
0.00
Extreme 0
0.00
10 years
0.00
Extreme 0
0.00
More quotes
Response Oncology, Inc. was, prior to the sales of its assets, a comprehensive cancer management company. As of May 20, 2002, the Company had liquidated substantially all of its operating assets and anticipates that the remaining assets will be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, the Company provided advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the non-medical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers.
More about the company